Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Am J Surg. 2019 Jan 3;218(1):157–163. doi: 10.1016/j.amjsurg.2018.12.067
Variable Odds Ratio 95% CI P-value
Age >65 years old 1.14 0.95 – 1.39 0.17
Male 0.96 0.81 – 1.14 0.66
Race
 White Reference
 Black 1.69 1.34 – 2.14 <0.001
 Hispanic 0.68 0.52 – 0.89 0.005
 Asian 2.23 1.75 – 2.84 <0.001
 Native American 1.00 0.44 – 2.28 0.996
Charlson/Deyo Comorbidity Score
 CDCC 0 Reference
 CDCC 1 1.27 1.06 – 1.52 0.009
 CDCC ≥2 1.06 0.87 – 1.28 0.57
Fibrosis score
 F0 (none to moderate fibrosis) Reference
 F1 (severe fibrosis or cirrhosis) 0.20 0.17 – 0.24 <0.001
Tumor size
 Tumor <3 cm Reference
 Tumor 3–5 cm 2.33 1.98 – 2.75 <0.001
 Tumor >5 cm 13.7 10.5 – 17.9 <0.001
Insurance status
 Private Reference
 Medicare 0.77 0.63 – 0.93 0.008
 Medicaid 0.82 0.64 – 1.06 0.13
 Other government 0.41 0.22 – 0.76 0.005
 None 1.07 0.66 – 1.76 0.78
Median income quartiles (by zip code)
 > $63,000 Reference
 $48,000–$62,999 1.13 0.93 – 1.38 0.22
 $38,000–$47,999 1.12 0.90 – 1.40 0.30
 < $38,000 0.99 0.78 – 1.26 0.95
Facility type
 Community cancer program Reference
 Comprehensive community cancer program 1.01 0.50 – 2.05 0.97
 Academic/research program 0.69 0.35 – 1.37 0.29
 Integrated network cancer program 0.48 0.23 – 1.00 0.050
Facility region
 New England/Mid Atlantic Reference
 South Atlantic 1.02 0.77 – 1.35 0.89
 North Central 0.94 0.74 – 1.19 0.62
 South Central 0.88 0.67 – 1.16 0.37
 Mountain 0.57 0.38 – 0.85 0.006
 Pacific 0.38 0.31 – 0.48 <0.001
Year of diagnosis
 2004 – 2009 Reference
 2010 – 2014 1.19 1.01 – 1.41 0.04

CI: confidence interval; CDCC: Charlson/Deyo Comorbidity Score